cGxP.wire https://validator.w3.org/feed/docs/rss2.html Nkarta to Present Initial NKX019 Autoimmune Data at ACR 2026 Adagene and Exelixis Advance SAFEbody ADC Programs Eir Partners Acquires Accumulus to Scale Life Sciences Nanoscope’s MOGENRY BLA Accepted by FDA for Retinitis Pigmentosa Fate Therapeutics Presents FT819 Clinical Data at CCR-West 2026 MannKind and Rose Pharma Partner on Inhaled GLP-1 Opus Genetics Advances OPGx-BEST1 Toward Phase 3 Context Therapeutics Doses First Patient in CT-202 Phase 1 Evommune Reports Phase 2b Setback for EVO756 in Atopic Dermatitis Leyden Labs Advances RIG-101 Toward Phase 2 in Asthma LUMA Vision Wins FDA Clearance for VERAFEYE Cardiac Platform Revvity to Acquire Human Cell Design for Metabolic Drug Discovery LabCentral Launches The Loop for Global Biotech Startups Quoin Pharmaceuticals Gains FDA Pediatric Designation for QRX003 Scinai Refocuses NanoAb Platform and CDMO Growth CAMP4 Therapeutics Prepares CMP-002 Phase 1/2 Trial for SYNGAP1 BridgeBio Advances Oral Infigratinib Toward Achondroplasia Launch Orphalan Launches Phase 3 Trial of Once-Daily Trientine Spyre Therapeutics Advances SPY003 in UC with Positive Phase 2 Data Labcorp Acquires MLM to Expand Global Clinical Trial Labs Avalyn Pharma Presents New AP01 Data in Pulmonary Fibrosis Structure Therapeutics Reports Positive Oral Weight-Loss Data Perosphere Technologies Reports New Clinical Data for ClotChek Intellia Therapeutics Gains FDA Priority Review for Lonvo-z in HAE BioAge Labs Begins Phase 2 Trial of Oral BGE-102 Amgen and AstraZeneca’s IMDELLTRA-IMFINZI Improves SCLC Survival Moonwalk Biosciences Raises $70 Million Series B Pharvaris Reports Positive Phase 3 CHAPTER-3 Data for Deucrictibant XR Altesa’s Vapendavir Reduces COPD Inflammation in Phase 2a GE HealthCare Advances StarGuide GX for Theranostics Definium Therapeutics Gains FDA Breakthrough Therapy Designation for DT120 in MDD Verastem Oncology Advances VS-7375 Across KRAS G12D Cancers Faeth Therapeutics Highlights PIKTOR Strategy Ahead of Phase 2 Data Kelun-Biotech’s WIN378 Advances to Phase 3 in Asthma Dyne Therapeutics Advances Z-Basivarsen Toward Phase 3 in DM1 Pulmovant Advances Mosliciguat Into Phase 3 After Positive PHocus Data Anitoa Adds Secure Cloud Connectivity to Portable qPCR AstraZeneca’s Tozorakimab Cuts COPD Exacerbations in Phase 3 Heru Launches PretestPro for Prime Diagnostic Headset Vor Bio Completes Phase 3 UPSTREAM MG Enrollment and Expands Telitacicept Into Ocular MG Harbour BioMed’s WIN378 Shows Positive Phase 2 Asthma Data BrainChild Bio Initiates Pivotal Phase 2 Trial of BCB-276 for DIPG Alebund’s AP308 Gets FDA IND Clearance for IgA Nephropathy Sernova and Seraxis Merge to Create BetaNova Biotherapeutics Abbott Wins FDA Approval for TactiFlex Duo AFib Catheter Johnson & Johnson Highlights New Neuropsychiatry Data Monte Rosa Advances MRT-6160 Into Phase 2 for Sjögren’s Disease Alpha-9 Oncology Starts Phase 1 GRPR Radiotherapeutic Trial NanoMosaic Advances Distributed Genetic Medicine Manufacturing Accro Bioscience Gains NMPA Clearance for AC-201 Vitiligo Trial